Publication: Real-Life Outcomes of Ocrelizumab Treatment from 3 Multiple Sclerosis Centers in Turkey
| dc.contributor.author | Vural, E. | |
| dc.contributor.author | Terzi, M. | |
| dc.contributor.author | Sunter, G. | |
| dc.contributor.author | Gunal, D. | |
| dc.contributor.author | Agan, K. | |
| dc.contributor.author | Boz, C. | |
| dc.date.accessioned | 2020-06-21T12:26:01Z | |
| dc.date.available | 2020-06-21T12:26:01Z | |
| dc.date.issued | 2019 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | [Vural, E. -- Sunter, G. -- Gunal, D. -- Agan, K.] Marmara Univ, Neurol, Istanbul, Turkey -- [Terzi, M.] Ondokuz Mayis Univ, Neurol, Samsun, Turkey -- [Boz, C.] Karadeniz Tech Univ, Neurol, Trabzon, Turkey -- | en_US |
| dc.description | 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDEN | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | European Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltd | en_US |
| dc.identifier.endpage | 751 | en_US |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.startpage | 751 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10630 | |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.wos | WOS:000485303103164 | |
| dc.language.iso | en | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.relation.journal | Multiple Sclerosis Journal | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Real-Life Outcomes of Ocrelizumab Treatment from 3 Multiple Sclerosis Centers in Turkey | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
